Jnba Financial Advisors Lexicon Pharmaceuticals, Inc. Transaction History
Jnba Financial Advisors
- $1.03 Billion
- Q2 2025
Shares
3 transactions
Others Institutions Holding LXRX
# of Institutions
129Shares Held
226MCall Options Held
431KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$203 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$58 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$14.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.85MShares$13.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$6.82 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $281M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...